SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CTEC: Cholestech any other investors?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: brian chan who wrote (55)5/1/1997 9:50:00 AM
From: John Kratus   of 710
 
Brian,

I think you may have misread the earnings report. CTEC made a profit of $2000, which is $0.00 per share. Actually, their operations lost $86,000, and they made $90,000 interest on their cash, so their operations still have not quite broken even.

But the big news, in my opinion is the increase in R&D spending, from $175,000 4Q96 to $436,000 4Q97. Without that increase CTEC would have earned $0.02 this quarter.

It seems as though management went into a cost-cutting crisis mode for about a year and a half to stem the losses and conserve money. That helped to lower the quarterly losses, but it didn't provide for a strong future, because any tech company needs R&D to bring out new products. CTEC is spending 11% of sales on R&D now, which should pay dividends later on.

Two other points: domestic sales increased nicely once again, but someone needs to kick a little international distributor butt. Doesn't CTEC have an Italian distributor and a Brazilian deal going on? Where are the results? Second point, I hope someone at CTEC is keeping a close watch on Hewlett-Packard/iStat developments.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext